RPG Life Sciences Quarterly Results for Trading Insights
RPGLIFE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹37 Cr
QSept 2025
RPG Life Sciences Quarterly Results Key Highlights
- Revenue of ₹197 Cr in Sept 2025 (-14.7% vs Mar 2025)
- Net Profit of ₹37 Cr in Sept 2025 (-68.4% vs Mar 2025)
- EBITDA of ₹55 Cr in Sept 2025 (-60.7% vs Mar 2025)
- Operating Margin of 21.0% in Sept 2025 (-16.0pp vs Mar 2025)
- Earnings Per Share of ₹22.28 in Sept 2025 (-68.6% vs Mar 2025)
RPG Life Sciences Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Dec 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 197 | 231 | 166 | 183 | 176 | -14.7% | - |
| Net Profit (₹ Cr) | 37 | 117 | 26 | 22 | 35 | - | - |
| EBITDA (₹ Cr) | 55 | 140 | 41 | 35 | 53 | - | - |
| EPS (₹) | 22.28 | 70.96 | 15.90 | 13.38 | 21.12 | - | - |
| Operating Margin (%) | 21.0% | 37.0% | 26.0% | 17.0% | 28.0% | - | - |
RPG Life Sciences Share Price Trend Around Quarterly Results
Visualize RPG Life Sciences's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.
Related Pages for RPG Life Sciences
Additional stock information and data for RPGLIFE
Revenue Trend (₹ Cr)
Dec 2025
183
Jun 2025
166
Mar 2025
231
Sept 2025
197
Net Profit Trend (₹ Cr)
Dec 2025
22
Jun 2025
26
Mar 2025
117
Sept 2025
37
Operating Margin Trend (%)
Dec 2025
17.0%
Jun 2025
26.0%
Mar 2025
37.0%
Sept 2025
21.0%
Sector Competitors - Quarterly Performance Comparison
Comparing RPG Life Sciences quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹406,351.37 Cr | 1718.0 | 14,875 | 3,125 | +10.8% | - | 21.0% | 132.2 |
|
Divis Laboratories
Sept 2025 |
₹155,471.67 Cr | 5850.0 | 2,860 | 689 | +7.1% | - | 24.1% | 225.3 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹134,945.00 Cr | 4051.3 | 3,219 | 591 | +11.3% | - | 18.4% | 231.0 |
|
Lupin
Sept 2025 |
₹102,578.78 Cr | 2298.3 | 6,921 | 1,485 | +23.2% | - | 21.5% | 71.0 |
|
Dr Reddys Laborator…
Sept 2025 |
₹101,601.09 Cr | 1196.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 73.9 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores